Minerva Neurosciences (NERV) Shares Outstanding (Diluted) (2019 - 2026)
Minerva Neurosciences' Shares Outstanding (Diluted) was 45.26 million in Q2 2026, up 497.9% from 7.57 million a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Minerva Neurosciences came in at 8.46 million, up 11.7% from FY2024.
- Shares Outstanding (Diluted) has now increased for three consecutive years, with a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 7.57 million in FY2024 (+16.4%), 6.51 million in FY2023 (+21.8%), 5.34 million in FY2022 (unchanged) and 5.34 million in FY2021 (+4.4%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2019.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for three straight quarters, with growth averaging 125.8% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.0% (Q3 2022) and 497.9% (Q2 2026) over the last five years.
- Per Business Quant data, NERV's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 43.9 million (Q1 2026), 8.46 million (Q4 2025) and 7.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Minerva Neurosciences | 158.21 Mn | 158.21 Mn | - | 45.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.26 Mn |
| Mar 31, 2026 | 43.90 Mn |
| Dec 31, 2025 | 8.46 Mn |
| Sep 30, 2025 | 7.57 Mn |
| Jun 30, 2025 | 7.57 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 7.57 Mn |
| Jun 30, 2024 | 7.57 Mn |
| Mar 31, 2024 | 7.57 Mn |
| Dec 31, 2023 | 6.51 Mn |
| Sep 30, 2023 | 7.57 Mn |
| Jun 30, 2023 | 5.51 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 5.34 Mn |
| Sep 30, 2022 | 5.34 Mn |
| Jun 30, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 5.34 Mn |
| Sep 30, 2021 | 5.34 Mn |
API Access
Minerva Neurosciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();